Centrul Medical Dr Negrisanu SRL

Timișoara 300456

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Studies at this site

• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) — Completed